Ameritas Investment Partners’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4,790
| Closed | -$184K | – | 3143 |
|
|
2023
Q2 | $184K | Buy |
4,790
+880
| +23% | +$22.6K | 0.01% | 1184 |
|
|
2023
Q1 | $90.5K | Hold |
3,910
| – | – | ﹤0.01% | 1595 |
|
|
2022
Q4 | $103K | Hold |
3,910
| – | – | ﹤0.01% | 1581 |
|
|
2022
Q3 | $76K | Buy |
3,910
+890
| +29% | +$17.9K | ﹤0.01% | 1696 |
|
|
2022
Q2 | $52K | Hold |
3,020
| – | – | ﹤0.01% | 1970 |
|
|
2022
Q1 | $49K | Hold |
3,020
| – | – | ﹤0.01% | 2073 |
|
|
2021
Q4 | $49K | Buy |
3,020
+554
| +22% | +$7.89K | ﹤0.01% | 2150 |
|
|
2021
Q3 | $31K | Hold |
2,466
| – | – | ﹤0.01% | 2461 |
|
|
2021
Q2 | $35K | Buy |
2,466
+1,357
| +122% | +$21.7K | ﹤0.01% | 2424 |
|
|
2021
Q1 | $17K | Hold |
1,109
| – | – | ﹤0.01% | 2641 |
|
|
2020
Q4 | $18K | Hold |
1,109
| – | – | ﹤0.01% | 2538 |
|
|
2020
Q3 | $13K | Hold |
1,109
| – | – | ﹤0.01% | 2613 |
|
|
2020
Q2 | $13K | Hold |
1,109
| – | – | ﹤0.01% | 2602 |
|
|
2020
Q1 | $15K | Hold |
1,109
| – | – | ﹤0.01% | 2350 |
|
|
2019
Q4 | $7K | Hold |
1,109
| – | – | ﹤0.01% | 2858 |
|
|
2019
Q3 | $6K | Hold |
1,109
| – | – | ﹤0.01% | 2913 |
|
|
2019
Q2 | $9K | Hold |
1,109
| – | – | ﹤0.01% | 2841 |
|
|
2019
Q1 | $22K | Hold |
1,109
| – | – | ﹤0.01% | 2339 |
|
|
2018
Q4 | $15K | Hold |
1,109
| – | – | ﹤0.01% | 2501 |
|
|
2018
Q3 | $41K | Hold |
1,109
| – | – | ﹤0.01% | 2100 |
|
|
2018
Q2 | $39K | Buy |
1,109
+394
| +55% | +$15.1K | ﹤0.01% | 2151 |
|
|
2018
Q1 | $33K | Hold |
715
| – | – | ﹤0.01% | 2162 |
|
|
2017
Q4 | $27K | Hold |
715
| – | – | ﹤0.01% | 2288 |
|
|
2017
Q3 | $43K | Hold |
715
| – | – | ﹤0.01% | 1988 |
|
|
2017
Q2 | $41K | Buy |
715
+162
| +29% | +$8.13K | ﹤0.01% | 2043 |
|
|
2017
Q1 | $30K | Buy |
+553
| New | +$31.2K | ﹤0.01% | 2171 |
|
Ameritas Investment Partners's KDNY Position: Q3 2023 in Review
Ameritas Investment Partners sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 4,790 shares — an estimated $184K sold.
Ameritas Investment Partners first reported a position in KDNY in Q1 2017 and held it in 26 quarters. The position peaked at $184K in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.
- Ameritas Investment Partners reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Ameritas Investment Partners sold 4,790 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $184K.
- Ameritas Investment Partners first reported a position in Chinook Therapeutics, Inc. Common Stock in Q1 2017 and held it in 26 quarters.
- Ameritas Investment Partners's Chinook Therapeutics, Inc. Common Stock position peaked at $184K in Q2 2023.
- 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.
Based on Ameritas Investment Partners's 13F filing for Q3 2023, filed 13 Nov 2023.